510(k) · Cleared
ClearedMBT Compass HT CA Software; MBT FAST Shuttle US IVD
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Bruker Daltonics GmbH & Co. KG · QBN Mass Spectrometry, Maldi Tof, Microorganism Identification, Cultured Isolates
Cleared on Aug 13, 2025 as substantially equivalent to K193419 (Bruker Daltonik GmbH, 2020) after a 90-day review. Its family tree reaches back 1 generation to 2020.
- Decided
- Aug 13, 2025
- Review
- 90 days
- Class
- Class II
- Product code
- QBN
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K193419 (2020). No later device cites it as a predicate yet.
- Root · 1 generation backK193419 MBT SepsityperBruker Daltonik GmbH · 2020
- This deviceK251495 MBT Compass HT CA Software; MBT FAST Shuttle US IVDBruker Daltonics GmbH & Co. KG · 2025
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K193419 | MBT Sepsityper | Bruker Daltonik GmbH | 2020 | — |
| 0 (this device) | K251495 | MBT Compass HT CA Software; MBT FAST Shuttle US IVD | Bruker Daltonics GmbH & Co. KG | 2025 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in QBN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new QBN device
- #1 K212461 Vitek MS Primescore 3.3 · 2 generations · no Class I recall
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K193419 | MBT SepsityperSummary page 5…ed code: QNJ III. PREDICATE DEVICE Trade/Device Name: MBT-CA System with MBT Sepsityper 510(k) Submitter/Holder: Bruker Daltonics GmbH & Co. KG 510(k) Reference: K193419 IV. DEVICE DESCRIPTION The MALDI Biotyper CA System uses MALDI (matrix-assisted laser desorption/ionization) TOF (time o… | 2020 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Its one ancestor has no recall.
- 1 other device also cites its predicate K193419.
How does its category compare?
All QBN devicesQBN Mass Spectrometry, Maldi Tof, Microorganism Identification, Cultured Isolates: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.
FDA decisions per year · QBN
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · QBN
Too few QBN 510(k)s in any year since 2007 to give a median.
Recalls per year · QBN
No recall names QBN since 2007.
Adverse event reports per year · QBN
2in 2025
MAUDE reports naming product code QBN, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 2 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 54 |
| 2021 | 0 | — | 0 | 163 |
| 2022 | 1 | — | 0 | 135 |
| 2023 | 0 | — | 0 | 39 |
| 2024 | 0 | — | 0 | 17 |
| 2025 | 1 | — | 0 | 2 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The MBT Sepsityper is a qualitative in vitro diagnostic device consisting of an MBT-CA (Sepsityper) software extension and a reagent kit (MBT Sepsityper Kit US IVD) for use in conjunction with other clinical and laboratory findings to aid in the early diagnosis of bacterial and yeast infections from positively flagged blood cultures using the MALDI Biotyper CA System. The MBT Sepsityper Kit US IVD is a disposable blood culture processing device that…
Read the full statement (266 words)
The MBT Sepsityper is a qualitative in vitro diagnostic device consisting of an MBT-CA (Sepsityper) software extension and a reagent kit (MBT Sepsityper Kit US IVD) for use in conjunction with other clinical and laboratory findings to aid in the early diagnosis of bacterial and yeast infections from positively flagged blood cultures using the MALDI Biotyper CA System.
The MBT Sepsityper Kit US IVD is a disposable blood culture processing device that includes associated reagents that are intended to concentrate and purify microbial cells from blood culture samples identified as positive by a continuous monitoring blood culture system and confirmed to demonstrate the presence of a single organism as determined by Gram stain. This sample preparation manual method is performed by laboratory health professionals in a clinical diagnostic setting. Subculturing of positive blood cultures is necessary to recover organisms for identification of organisms not identified by the MBT-CA System, for susceptibility testing and for differentiation of mixed growth.
Positive MBT Sepsityper results do not rule out co-infection with organisms that may not be detected by the MBT-CA System. Results of the MBT Sepsityper should not be used as the sole basis for diagnosis, treatment, or other patient management decisions. Results of the MBT Sepsityper should be correlated with Gram stain results and used in conjunction with other clinical and laboratory findings to aid in the diagnosis of bacterial and yeast bloodstream infections.
Organisms recovered from positive blood culture bottles that are suitable for identification using the MBT Sepsityper Kit US IVD and MBT-CA Systems are listed in the MALDI Biotyper CA System Package Insert Reference Library.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K251495 · printed Nov 6, 2026
Cite this page
510(k) Report. “K251495: MBT Compass HT CA Software; MBT FAST Shuttle US IVD.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K251495
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026